Trial Profile
The efficacy of silodosin in patients with acute urinary retention related to benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia; Urinary retention
- Focus Therapeutic Use
- 19 Sep 2013 New trial record